Patent details

Basic Information

Publication number:

EP3230249

PCT Application Number:

US2015064785

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP158664052

PCT Publication Number:

WO2016094554

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

2-DODECYL-6-METHOXYCYCLOHEXA-2,5-DIENE-1,4-DIONE AS A CANCER THERAPEUTIC

French Title of Invention:

2-DODÉCYL-6-MÉTHOXYCYCLOHEXA-2,5-DIÈNE-1,4-DIONE UTILISABLE EN TANT QU'AGENT ANTI-CANCÉREUX

German Title of Invention:

2-DODECYL-6-METHOXYCYCLOHEXA-2,5-DIEN-1,4-DION ALS KREBSTHERAPEUTIKUM

SPC Number:

Dates

Filing date:

09/12/2015

Grant date:

08/04/2020

EP Publication Date:

18/10/2017

PCT Publication Date:

16/06/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/04/2020

EP B1 Publication Date:

08/04/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/12/2020

Expiration date:

09/12/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/04/2020

 

 

Name:

Middle Tennessee State University

Address:

1301 E. Main St., Murfreesboro, TN 37132, United States (US)

Inventor

1

Name:

GAO, Ying

Address:

United States (US)

2

Name:

ALTMAN, Elliot

Address:

United States (US)

Priority

Priority Number:

201462089578 P

Priority Date:

09/12/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/122; A61K 31/337; A61K 31/395; A61K 31/555; A61K 31/704; A61K 45/06; A61P 35/00; C07C 50/04;

Publication

European Patent Bulletin

Issue number:

202015

Publication date:

08/04/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages